resTORbio, Inc.

If you purchased resTORbio, Inc. securities and would like to join the action, please click "Join This Action" below.

resTORbio Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of resTORbio, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm

April 29, 2020.

New York, New York—Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger between resTORbio, Inc. (NASDAQ: TORC) and Adicet Bio, Inc. is fair to resTORbio shareholders. On behalf of resTORbio shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

The resTORbio merger investigation concerns whether resTORbio and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible consideration for resTORbio shareholders; and (2) disclose all material information necessary for resTORbio shareholders to adequately assess and value the merger consideration.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.


Scroll to Top